Diabetic Neuropathy Market Size, Share & Trends 2024-2031
Diabetic Neuropathy Market Overview
The global diabetic neuropathy market, valued at USD 3,775.4 million in 2022, is expected to expand to USD 6,298.1 million by 2031, achieving a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
This market includes various types of diabetic neuropathy such as autonomic, proximal, focal, and peripheral neuropathy. The market growth is driven by rising diabetes prevalence, increased awareness, advancements in pain management research, and ongoing market innovations.
For More Insights Request Sample Report:https://www.datamintelligence.com/download-sample/diabetic-neuropathy-market
Diabetic Neuropathy Market Growth
The global diabetic neuropathy market is expanding due to the rising prevalence of diabetes. According to the International Diabetes Federation's 2021 report, approximately 537 million adults aged 20-79 were living with diabetes. This number is projected to increase to about 643 million by 2030 and reach around 783 million by 2045. Notably,
a significant portion of these individuals—about three-quarters—reside in low- and middle-income countries, and nearly half of them remain undiagnosed, totaling over 240 million people. In 2021 alone, diabetes was responsible for more than 6.7 million deaths and incurred approximately USD 966 billion in healthcare costs, accounting for nearly 9% of total health expenditures for adults.
For Customized Report:https://www.datamintelligence.com/customize/diabetic-neuropathy-market
View Full Report:https://www.datamintelligence.com/enquiry/diabetic-neuropathy-market
Segmentations
By Type :Peripheral Neuropathy, Non-Pharmacological Treatment
By Treatment Type :Pharmacological Treatment, Non-Pharmacological Treatment
By Distribution Channel :Hospitals, Clinics, Retail Pharmacies, Online Pharmacy
Key players
-
Depomed Pharma
-
Eli Lilly
-
Daiichi Sankyo
-
Teva Pharmaceutical Industries Ltd.
-
Xenoport
-
Grünenthal
-
Johnson & Johnson
-
Pfizer
-
GlaxoSmithKline
-
Boehringer Ingelheim
Related Reports:
Diabetic Neuropathic Foot Ulcers:
https://www.datamintelligence.com/research-report/diabetic-neurotherapy-foot-ulcers-market
Diabetic Retinopathy:
https://www.datamintelligence.com/research-report/diabetic-retinopathy-market
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai.K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian